• Recently, Ondas showcased its unified autonomous defense architecture at Eurosatory, introducing systems such as Iron Wave, Dual Shield, MODUS, Scout Cyber-over-RF, Iron Arrow, and LADOS while highlighting its ONBERG European joint venture to support regional manufacturing and deployment.
• Alongside these technology launches, the company reported very large year-on-year Q1 revenue growth, a substantial US$457 million defense backlog, and deepening AI collaboration with Palantir, underscoring how its drone-intercept and autonomous systems are gaining traction across modern defense applications.
• We’ll now examine how this expanding defense backlog and new autonomous systems portfolio could influence Ondas’ existing investment narrative.

The latest GPUs need a type of rare earth metal called Dysprosium and there are only 32 companies in the world exploring or producing it. Find the list for free.

Ondas Investment Narrative Recap

To own Ondas, you need to believe its autonomous defense and counter‑drone platforms can convert a large defense backlog into durable, profitable revenue while the company manages heavy dilution and a still‑evolving cost base. The Eurosatory launch and US$457 million defense backlog reinforce the near term catalyst around OAS execution, but insider selling and enlarged share capacity keep funding and dilution risk front and center for shareholders watching the next few quarters.

The Eurosatory unveiling of Iron Wave, Dual Shield, MODUS, Scout Cyber-over-RF, Iron Arrow and LADOS is especially relevant here, because it shows how Ondas is turning its Palantir‑enabled AI work and ONBERG joint venture into a more complete “system of systems” offering. That matters for the backlog catalyst, since integrating air, ground, sensing and command products into a single architecture is what needs to work in practice for those large defense commitments to convert efficiently.

Yet beneath the contract headlines, investors should be aware that the same growth story sits alongside very heavy dilution and insider selling pressure…

Ondas' narrative projects $1.0 billion revenue and $114.4 million earnings by 2029. This requires 119.3% yearly revenue growth and an earnings decrease of $19.8 million from $134.2 million today.

Uncover how Ondas' forecasts yield a $20.12 fair value, a 112% upside to its current price.

Exploring Other Perspectives

Before this news, the most cautious analysts already factored in rapid revenue growth of about 179 percent a year yet still saw earnings staying negative, so compared with their concern about slower counter drone build outs and complex multi domain integration, this latest backlog and product push could either soften or reinforce that more pessimistic view depending on how effectively Ondas executes from here.

Explore 14 other fair value estimates on Ondas - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Ondas research is our analysis highlighting 4 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Ondas research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ondas' overall financial health at a glance.

No Opportunity In Ondas?

Our top stock finds are flying under the radar-for now. Get in early:

• Uncover the next big thing with 23 elite penny stocks that balance risk and reward.
• Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.